Ingram Micro Instruments CAD detector empowers the research and development and quality control of peptide weight-loss drugs and supports the innovative development of the GLP-1 drug industry
Ingram Micro InstrumentsCADThe detector empowers the research and development and quality control of peptide weight-loss drugs, helpingGLP-1Innovation and development of pharmaceutical industry

In recent years, withGLP-1receptor agonists (GLP-1 Receptor Agonists), represented by peptide slimming drugs, has quickly become a hot spot in the global pharmaceutical industry. From diabetes treatment to obesity management, to the continuous expansion of new indications such as cardiovascular disease, metabolic syndrome and fatty liver disease, peptide drugs are showing huge market potential. As the R&D and industrialization process of innovative drugs accelerates, the demand for high-performance analysis and detection technology is also growing.
As a domestic high-end electrospray detector (Charged Aerosol Detector,CAD), Ingram Micro Instruments continues to advanceCADThe application of technology in the field of biopharmaceuticals provides high-sensitivity and high-stability analysis solutions for peptide drug research and development, process development and quality control.
GLP-1Drug-like drugs lead a new era of peptide drug development

In recent years,GLP-1Such drugs have achieved rapid growth in the global market, and representative products include semaglutide (Semaglutide), tilpotide (Tirzepatide) and liraglutide (Liraglutide)wait. This type of drugs not only performs well in blood sugar control, but also shows good clinical value in weight management, cardiovascular protection, etc., pushing the global peptide drug market into a new stage of development.
At the same time, more and more long-actingGLP-1, multi-target agonists and oral peptide drugs have entered the research and development stage, placing higher requirements on the sensitivity, stability and versatility of analytical methods.
Peptide drug analysis faces new challenges
Peptide drugs usually have complex molecular structures, diverse physical and chemical properties, and rich modification types. During the R&D and production processes, a comprehensive analysis of active ingredients, process impurities, degradation products and excipients is required to ensure product quality, safety and batch consistency.
Typical analysis content includes:
Purity analysis of peptide raw materials;
Detection of synthetic by-products and truncated peptides;
Analysis of degradation products such as oxidation and deamidation;
Analysis of excipients and stabilizers in preparations;
Process development process monitoring;
stability studies;
quality control (QC) and release testing.
CADDetector assists in quality analysis of peptide drugs

Ingram Micro InstrumentsCADThe detector adopts the principle of aerosol electrification detection and has stable response to most non-volatile compounds. It does not depend on whether the compound has specific UV absorption and can be used as an important universal detector for liquid chromatography.
In peptide drug analysis,CADCan be applied to:
Evaluation of the purity of peptide APIs;
Analysis of process impurities and by-products;
Synthesis process monitoring;
Stability studies and degradation product detection;
Analysis of preparation excipients;
HPLCmethod development;
QCRoutine laboratory testing.
For some excipients, lipids and polymers with weak UV response or large response differences,CADCan provide good complementary detection capabilities with UV detectors (UV) and mass spectrometry (MS) complement each other and improve the integrity of the analysis results.
Analysis of long-acting preparations and excipients brings new application opportunities
In order to extend the half-life in vivo and improve patient compliance, manyGLP-1Drug-like drugs adopt technical routes such as fatty acid modification, polymer modification or sustained-release preparations. At the same time, polyethylene glycol (PEG) derivatives, surfactants, sugar stabilizers and buffer salts and other excipients.
These non-volatile excipients also require quantitative analysis during the quality control process.CADThe detector does not rely on chromophores to achieve detection and can be used in:
PEGandPEGDerivative analysis;
Analysis of components related to fatty acid modification;
Surfactant analysis;
Analysis of sugar stabilizers;
Buffer salt and inorganic ion monitoring;
Consistency evaluation of preparation excipients.
By combining with liquid chromatography,CADIt can help R&D personnel gain a more comprehensive understanding of formulation composition and provide reliable data support for process optimization and product release.

From R&D to production,CADCovering the entire process analysis of peptide drugs
Focusing on the research and development and industrialization of peptide drugs, Ingram Micro InstrumentsCADDetectors can be used in several key areas:
application stage | Typical analysis objects |
Raw material research and development | Peptide raw materials, modified peptides |
process development | Intermediates, impurities, by-products |
Formulation development | PEGDerivatives, surfactants, stabilizers |
Stability studies | Degradation products, oxidation products |
method development | HPLCAnalysis method establishment and optimization |
QCrelease | Quality control of raw materials, preparations and excipients |
CADThe detector has the characteristics of universal response, high sensitivity, wide linear range, good repeatability and compatibility with gradient elution, and can provide stable and reliable analytical support for the development and production of peptide drugs.
Continuous innovation to serve the high-quality development of the biopharmaceutical industry
along withGLP-1With the rapid development of drug-like drugs and new generation peptide therapies, high-performance analysis and detection equipment will play an increasingly important role in the research and development, process development and quality control of innovative drugs.
Ingram Micro Instruments will continue to advanceCADInnovate detection technology and expand its application in the fields of peptide drugs, nucleic acid drugs, biological agents, natural products and advanced preparations, providing scientific research institutions, biotechnology enterprises,CRO/CDMOand pharmaceutical companies to provide more efficient and reliable analysis and testing solutions, and use domestic innovative technologies to help the high-quality development of China's biopharmaceutical industry.
Ingram Micro Instruments——Eyes that explore the unknown world (The Eyes That Venture into the Unknown)。
View More from This Booth
The event concluded | Ingram Micro Instruments appeared at the 10th Small Nucleic Acid Conference, using domestic CAD technology to empower nucleic acid drug quality control innovation
Ingram Micro's CAD detector enables full-process analysis of nucleic acid drugs, facilitating the high-quality development of a new generation of nucleic acid drugs
Ingram Micro Instruments' CAD users' plan to assist scientific research growth is officially launched - using the power of scientific research to jointly build a road to domestic innovation
Ingram Micro Instruments' CAD users' plan to assist scientific research growth is officially launched - using the power of scientific research to jointly build a road to domestic innovation

